Oliver Lenz
11Patents
3h-index
22Co-inventors
56Inventor score
Filing activity: Mar 27, 2006 → Mar 13, 2019
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8022077B2 | Pyrido[2,3-d]pyrimidines useful as HCV inhibitors, and methods for the preparation thereof | Human Necessities | 29 | Expired |
| US8030318B2 | Fused bicyclic inhibitors of HCV | Human Necessities | 28 | Expired |
| US7977342B2 | HCV inhibiting bi-cyclic pyrimidines | Emerging Cross-Sectional Technologies | 8 | Active |
| US9290502B2 | Pteridines useful as HCV inhibitors and methods for the preparation thereof | Emerging Cross-Sectional Technologies | 2 | Active |
| US10328405B2 | Process for the production of solid cooling agents | Chemistry; Metallurgy | 1 | Active |
| US10589241B2 | Method for storing cooling agents | Performing Operations; Transporting | 1 | Active |
| US9951075B2 | Pteridines useful as HCV inhibitors and methods for the preparation thereof | Emerging Cross-Sectional Technologies | 0 | Active |
| US9708328B2 | Pteridines useful as HCV inhibitors and methods for the preparation thereof | Emerging Cross-Sectional Technologies | 0 | Active |
| US9987277B2 | Carboxamide 4-[(4-pyridyl)amino] pryimidines for the treatment of hepatitis C | Human Necessities | 0 | Active |
| US12403076B2 | Compositions comprising odorless 1,2-pentanediol | Chemistry; Metallurgy | 0 | Active |
| US10973801B2 | Capsid assembly modulator dosing regimen | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.